Morpholino

MO2-itga6a

ID

ZDB-MRPHLNO-121219-5

Name

MO2-itga6a

Previous Names

None

Target

itga6a (1)

Sequence

5' - CTGTTGTATGAAAAATATAGCCCTT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-itga6a

No data available

Phenotype

Phenotype resulting from MO2-itga6a

No data available

Phenotype of all Fish created by or utilizing MO2-itga6a

Phenotype	Fish	Conditions	Figures
vertical myoseptum malformed, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 7 from Goody et al., 2012
myotome muscle cell increased length, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 , Fig. 7 from Goody et al., 2012
myotome muscle tendon junction U-shaped, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 from Goody et al., 2012
myotome decreased width, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 from Goody et al., 2012
whole organism decreased length, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 from Goody et al., 2012
vertical myoseptum U-shaped, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle tendon junction malformed, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 , Fig. 5 from Goody et al., 2012
myotome muscle tendon junction U-shaped, abnormal	WT + MO1-itga6a + MO2-itga6a + MO9-tp53	standard conditions	Fig. 5 from Goody et al., 2012
vertical myoseptum U-shaped, abnormal	WT + MO1-itga6a + MO2-itga6a + MO9-tp53	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle cell increased length, abnormal	WT + MO1-itga6a + MO2-itga6a + MO9-tp53	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle tendon junction malformed, abnormal	WT + MO1-itga6a + MO2-itga6a + MO9-tp53	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle tendon junction malformed, abnormal	lamc1^{wi390Tg/wi390Tg} + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 from Goody et al., 2012
trunk decreased length, abnormal	lamc1^{wi390Tg/wi390Tg} + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 from Goody et al., 2012
post-vent region decreased length, abnormal	lamc1^{wi390Tg/wi390Tg} + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 from Goody et al., 2012
vertical myoseptum U-shaped, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 from Goody et al., 2012
vertical myoseptum U-shaped, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	chemical treatment: NAD(+)	Fig. 5 from Goody et al., 2012
myotome muscle tendon junction U-shaped, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle tendon junction U-shaped, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	chemical treatment: NAD(+)	Fig. 5 from Goody et al., 2012
myotome muscle cell degenerate, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle cell degenerate, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	chemical treatment: NAD(+)	Fig. 5 from Goody et al., 2012
vertical myoseptum malformed, abnormal	mai1Tg + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 7 from Goody et al., 2012
myotome muscle cell increased length, abnormal	mai1Tg + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 7 from Goody et al., 2012

Citations